Bionet Cash Flow Quality Index
Bionet cash flow quality index. Bionet (1784) has a Cash Flow Quality Index of 2.59x as of June 2026. Operating cash flow of NT$51.22 Million exceeds net income of NT$19.80 Million, indicating high earnings quality where cash backs reported profits. See financial agility of Bionet to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Bionet (2018–2025)
Cash flow quality index of Bionet from 2018 to 2025. Historical Cash Flow Quality Index for Bionet across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Bionet to assess how comfortably operating cash covers total debt obligations.
Bionet Cash Flow Quality Index by Year (2018–2025)
Bionet cash flow quality index by year from 2018 to 2025. Year-by-year earnings quality comparison for Bionet. For the full cash flow conversion analysis, see Bionet (1784) cash flow conversion.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.88x | NT$148.04 Million | NT$51.43 Million | ▲ +36.5% |
| 2024 | 2.11x | NT$176.49 Million | NT$83.70 Million | ▲ +47.5% |
| 2023 | 1.43x | NT$153.09 Million | NT$107.08 Million | ▼ -42.6% |
| 2022 | 2.49x | NT$94.65 Million | NT$37.97 Million | ▲ +639.8% |
| 2021 | 0.34x | NT$13.88 Million | NT$41.19 Million | ▼ -97.1% |
| 2020 | 11.47x | NT$73.66 Million | NT$6.42 Million | ▲ +2823.6% |
| 2019 | 0.39x | NT$2.67 Million | NT$6.80 Million | ▲ +173.3% |
| 2018 | -0.54x | NT$-12.97 Million | NT$24.23 Million | — |